전일 마감가:
$1.96
열려 있는:
$1.94
하루 거래량:
95,003
Relative Volume:
0.42
시가총액:
$117.77M
수익:
$14.18M
순이익/손실:
$-82.66M
주가수익비율:
-1.4846
EPS:
-1.3
순현금흐름:
$-50.80M
1주 성능:
-7.66%
1개월 성능:
+10.92%
6개월 성능:
-2.53%
1년 성능:
-1.03%
시어 Stock (SEER) Company Profile
명칭
Seer Inc
전화
650-453-0000
주소
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
SEER을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SEER
Seer Inc
|
1.93 | 117.77M | 14.18M | -82.66M | -50.80M | -1.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
505.34 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.00 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
630.92 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
258.14 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
249.39 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
시어 Stock (SEER) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-07-05 | 재개 | JP Morgan | Neutral |
2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-08-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2021-10-15 | 재개 | Cowen | Outperform |
2020-12-29 | 개시 | BofA Securities | Neutral |
2020-12-29 | 개시 | Cowen | Outperform |
2020-12-29 | 개시 | JP Morgan | Overweight |
2020-12-29 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
시어 주식(SEER)의 최신 뉴스
Seer (NASDAQ:SEER) Shares Down 2.5% – What’s Next? - Defense World
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 | SEER Stock News - GuruFocus
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewswire
Seer, Inc. to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq
Seer Earnings Preview: Proteomics Pioneer Readies Q1 2025 Financial Results for May 13 Release - Stock Titan
Veracyte data joins NCI SEER database for research - Investing.com
Cadwell invests in Australian company Seer Medical - Yahoo
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics - Yahoo Finance
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
The SEER Group Expands in Oregon with Acquisition of Alpine Heating & Air Conditioning - Yahoo Finance
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - marketscreener.com
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
시어 (SEER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
시어 주식 (SEER) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
자본화:
|
볼륨(24시간):